Ampio Pharmaceuticals
AMPE
#11262
Rank
A$0.29 M
Marketcap
A$0.26
Share price
0.00%
Change (1 day)
117.32%
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -A$12.93 Million

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -A$23.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -A$12.41 Million-47.14%
2022 -A$23.48 Million-4.36%
2021 -A$24.55 Million7.42%
2020 -A$22.85 Million16.62%
2019 -A$19.6 Million-140.1%
2018 A$48.84 M-165.49%
2017 -A$74.59 Million170.77%
2016 -A$27.55 Million-30.16%
2015 -A$39.45 Million-29.73%
2014 -A$56.13 Million59.2%
2013 -A$35.26 Million111.58%
2012 -A$16.67 Million-36.57%
2011 -A$26.27 Million127.2%
2010 -A$11.57 Million758.38%
2009 -A$1.35 Million3105.94%
2008 -A$0.05 Million0.79%
2007 -A$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.66 B-303,714.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.92 B-80,116.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.69 B-94,365.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.42 B-59,947.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
A$0.13 B-1,158.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.41 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA